Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

ANGSTREM-T Constructs Semiconductor Manufacturing Plant

Published 7/2/2008

Russian semiconductor manufacturer ANGSTREM-T has selected M + W Zander as project engineer to construct a 200mm wafer production plant at its Zelenograd campus. The 6,000-sm cleanroom facility is slated for completion in late 2009. M +W Zander is based in Germany.

Read More

Johnson Medtech Opens Shajing Cleanroom

Published 7/2/2008

Medical device manufacturer Johnson Medtech opened its 14,000-sm cleanroom facility in Shajing, China, in late June of 2008. Comprised of four cleanrooms on three floors, the project includes three ISO 8 Class 100,000 cleanrooms, an ISO 6 Class 1,000 cleanroom, a testing laboratory, and an engineering office. The facility will support increased production of medical devices and subassemblies. Additionally, construction will begin in July of 2008 on a control manufacturing area with assembly line and plastic injection workshop.

Read More

Medical Research Council Constructs Laboratory of Molecular Biology

Published 7/2/2008

The Medical Research Council has selected HBG to build the £197 million Laboratory of Molecular Biology at the Cambridge Biomedical Campus in the United Kingdom. Designed by RMJM, the 32,500-sm laboratory will be supported by over 780 structural piles to mitigate vibration and will include an underground heat recovery pipe system. A 4,600-sm energy center will also be built. Construction will begin by year-end 2008 with completion expected in early 2012. The construction cost for the laboratory is £140 million.

Read More

Merck Expands Durham Vaccine Campus

Published 7/2/2008

Merck is building a $100 million, 110,000-sf pharmaceutical production facility in the Treyburn Corporate Park in Durham, N.C. Comprised of quality testing labs, a sterile processing plant, and packaging, the project is slated for completion in 2010 and represents the second phase of expansion at Merck’s vaccine manufacturing complex. The first $300 million, 235,000-sf phase was completed in spring of 2008. The third phase, a $300 million manufacturing, warehouse, and administrative facility, will reach completion in 2011.

Read More

University of Minnesota Plans Plant Pathogen Lab

Published 7/2/2008

The University of Minnesota will construct a plant pathogen laboratory with greenhouses on its St. Paul campus. The project was approved by the USDA’s Animal and Plant Health Inspection Service in June of 2008 and will accommodate research on diseases such as the virulent stem rust Ug99. The secure facility will feature advanced air filtration and containment technologies.

Read More